Skip to main content
رجوع
Watch Compare

LifeMD, Inc.

جودة البيانات: 100%
مُدرج أيضًا باسم LFMDP Nasdaq
LFMD
Nasdaq Services Health Services
KWD 3.41
▼ KWD 0.07 (-1.87%)
القيمة السوقية: 163.35 M
السعر
KWD 3.41
القيمة السوقية
163.35 M
نطاق اليوم
KWD 3.37 — KWD 3.54
نطاق 52 أسبوعًا
KWD 2.56 — KWD 15.84
حجم التداول
649,804
فتح KWD 3.45
متوسط 50 يوم / 200 يوم
KWD 3.36
1.33% above
متوسط 50 يوم / 200 يوم
KWD 5.86
41.94% below

Quick Summary

النقاط الرئيسية

Revenue grew 20.23% annually over 5 years — strong growth
Generating 6.41 M in free cash flow
P/E of 11.38 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 28.89%
Capital efficient — spends only 0.96% of revenue on capex

النمو

Revenue Growth (5Y)
20.23%
أعلى من متوسط القطاع (4.21%)
Revenue (1Y)-8.66%
Earnings (1Y)N/A
FCF Growth (3Y)-13.75%

الجودة

Return on Equity
N/A
ROIC-62.62%
Net Margin7.40%
Op. Margin-3.95%

الأمان

Debt / Equity
N/A
Current Ratio0.73
Interest Coverage-5.64

التقييم

PE (TTM)
11.38
أعلى من متوسط القطاع (-1.17)
P/B Ratio124.28
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Services (502 نظير)
المقياس السهم وسيط القطاع
P/E 11.4 -1.2
P/B 124.3 1.4
ROE % — -15.7
Net Margin % 7.4 -18.3
Rev Growth 5Y % 20.2 4.2
D/E — 0.4

ETFs Holding This Stock

BRSIX BRSIX
0.31% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.08% weight
DTSGX DTSGX
0.04% weight
WSMGX WSMGX
0.04% weight
GSTOX GSTOX
0.02% weight
GINUX GINUX
0.02% weight
GSZPX GSZPX
0.02% weight
GSIOX GSIOX
0.02% weight
GSCOX GSCOX
0.02% weight
GSROX GSROX
0.02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -8.66% Revenue Growth (3Y) 12.79%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 20.23% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 194.06 M Net Income (TTM) 14.35 M
ROE N/A ROA 20.57%
Gross Margin 85.72% Operating Margin -3.95%
Net Margin 7.40% Free Cash Flow (TTM) 6.41 M
ROIC -62.62% FCF Growth (3Y) -13.75%
Safety
Debt / Equity N/A Current Ratio 0.73
Interest Coverage -5.64 Asset Turnover 2.78
Working Capital -15.58 M Tangible Book Value -243,984
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 11.38 Forward P/E N/A
P/B Ratio 124.28 P/S Ratio 0.84
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 3.92%
Market Cap 163.35 M Enterprise Value 163.35 M
Per Share
EPS (Diluted TTM) 0.25 Revenue / Share 4.05
FCF / Share 0.13 OCF / Share 0.17
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.96% FCF Conversion 44.65%
SBC-Adj. FCF -3.83 M Growth Momentum -28.89

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 194.06 M 212.45 M 152.55 M 119.03 M 92.88 M
Net Income 14.35 M -18.88 M -20.60 M -45.54 M -60.90 M
EPS (Diluted) 0.25 — — — —
Gross Profit 166.34 M 188.39 M 133.65 M 100.37 M 74.88 M
Operating Income -7.67 M -16.14 M -14.49 M -43.45 M -54.30 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 1.36 M 2.18 M 2.60 M 1.28 M 3.02 M
Income Tax 45,721.0 402,000.0 428,000.0 360,700.0 7,700.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 70.41 M 72.46 M 58.48 M 25.67 M 49.92 M
Total Liabilities 47.25 M 76.51 M 52.91 M 32.97 M 24.10 M
Shareholders' Equity 23.16 M -5.49 M 3.51 M -11.40 M 22.74 M
Total Debt — — — — —
Cash & Equivalents — 35.00 M 33.15 M 3.96 M 41.33 M
Current Assets 51.83 M 48.73 M 42.60 M 11.31 M 44.92 M
Current Liabilities 41.57 M 60.26 M 34.78 M 31.37 M 22.83 M